Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$654M |
| 2 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$241M |
| 3 |
iShares Gold Trust
IAU
|
+$232M |
| 4 |
VanEck Oil Services ETF
OIH
|
+$200M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$165M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$852M |
| 2 |
Microsoft
MSFT
|
+$575M |
| 3 |
Carvana
CVNA
|
+$540M |
| 4 |
Target
TGT
|
+$430M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.49% |
| 2 | Financials | 5.96% |
| 3 | Consumer Discretionary | 5.3% |
| 4 | Healthcare | 4.99% |
| 5 | Communication Services | 3.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CANO
2976
DELISTED
Cano Health, Inc.
CANO
| $947K | ﹤0.01% |
1,491
-13,268
| -90% | -$8.36M |
|
2977
Banco Bilbao Vizcaya Argentaria
BBVA
$154B
| $946K | ﹤0.01% |
166,295
-34,400
| -17% | -$211K |
|
2978
CALL
Prudential Financial
PRU
$42.4B
| $945K | ﹤0.01% |
8,000
-184,000
| -96% | -$20.9M |
|
2979
Adtran
ADTN
$689M
| $944K | ﹤0.01% |
51,167
+3,579
| +8% | +$70.9K |
|
2980
Vaalco Energy
EGY
$570M
| $944K | ﹤0.01% |
+144,499
| New | +$757K |
|
2981
Karyopharm Therapeutics
KPTI
$43.5M
| $942K | ﹤0.01% |
8,519
-11,754
| -58% | -$1.46M |
|
2982
Pyxis Oncology
PYXS
$168M
| $942K | ﹤0.01% |
233,129
+229,923
| +7,172% | +$1.68M |
|
2983
Relmada Therapeutics
RLMD
$557M
| $942K | ﹤0.01% |
34,905
+29,891
| +596% | +$618K |
|
|
JYAC
2984
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
| $938K | ﹤0.01% |
95,343
| – | – |
|
2985
Prothena Corp
PRTA
$425M
| $937K | ﹤0.01% |
25,585
-74,703
| -74% | -$2.69M |
|
2986
AMERISAFE
AMSF
$543M
| $936K | ﹤0.01% |
18,842
+1,725
| +10% | +$88.1K |
|
2987
Relay Therapeutics
RLAY
$4.1B
| $936K | ﹤0.01% |
31,260
-128,355
| -80% | -$3.11M |
|
2988
Agios Pharmaceuticals
AGIO
$1.79B
| $934K | ﹤0.01% |
32,060
-120,994
| -79% | -$3.7M |
|
2989
Vanda Pharmaceuticals
VNDA
$307M
| $932K | ﹤0.01% |
82,384
-69,490
| -46% | -$913K |
|
2990
Anavex Life Sciences
AVXL
$255M
| $931K | ﹤0.01% |
75,596
-141,353
| -65% | -$1.74M |
|
2991
Banc of California
BANC
$3.03B
| $928K | ﹤0.01% |
47,942
+5,255
| +12% | +$104K |
|
|
GRP.U
2992
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $927K | ﹤0.01% |
12,008
-34,569
| -74% | -$2.63M |
|
2993
Ichor Holdings
ICHR
$2.62B
| $926K | ﹤0.01% |
25,987
+2,863
| +12% | +$111K |
|
|
MAXN
2994
DELISTED
Maxeon Solar Technologies
MAXN
| $926K | ﹤0.01% |
640
-102
| -14% | -$117K |
|
|
KC
2995
Kingsoft Cloud Holdings
KC
$3.34B
| $925K | ﹤0.01% |
152,356
-210,492
| -58% | -$1.71M |
|
2996
QuidelOrtho
QDEL
$1.14B
| $925K | ﹤0.01% |
8,223
-16,120
| -66% | -$1.72M |
|
2997
Vertiv
VRT
$93B
| $925K | ﹤0.01% |
66,068
+18,935
| +40% | +$337K |
|
2998
Herc Holdings
HRI
$5.02B
| $923K | ﹤0.01% |
5,522
-9,685
| -64% | -$1.53M |
|
2999
Kymera Therapeutics
KYMR
$8.51B
| $923K | ﹤0.01% |
21,799
-59,852
| -73% | -$2.53M |
|
3000
Preferred Bank
PFBC
$1.24B
| $923K | ﹤0.01% |
12,466
-755
| -6% | -$58.5K |
|
Similar funds
Citigroup's Q1 2022 Portfolio in Review
As of Q1 2022, Citigroup held 6,926 positions worth $165B, down 12% from $187B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citigroup withdrew a net $11.2B in Q1 2022, closing 497 positions and reducing 3,025 holdings. Its most notable exit was Xilinx Inc, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in ProShares UltraPro Short QQQ worth $126M.
- Citigroup's largest Q1 2022 buy was ProShares UltraPro Short QQQ: 149,740 shares worth $126M.
- Citigroup added most to iShares Russell 2000 ETF in Q1 2022, an estimated $654M increase.
- Citigroup's biggest Q1 2022 reduction was Apple, cutting an estimated $852M.
- Citigroup fully exited Xilinx Inc in Q1 2022, selling an estimated $235M.
- Citigroup's ten largest holdings make up 28% of its $165B portfolio in Q1 2022.
- Citigroup opened 1,006 new positions and closed 497 in Q1 2022.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $165B.
Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.